Postoperative adjuvant therapy following radical resection for intrahepatic cholangiocarcinoma: A multicenter retrospective study
暂无分享,去创建一个
Wei Guo | Yongyi Zeng | Weiping Zhou | J. Lou | X. Bi | Jingdong Li | Fuyu Li | Ya-min Zheng | Lei Wang | Jianming Wang | Manjun Deng | Jian Wang | Shu-guo Zheng | Q. Ke | S. Cheng | Weiping Zhou
[1] K. Lillemoe,et al. Predictors of adjuvant treatment and survival in patients with intrahepatic cholangiocarcinoma who undergo resection. , 2019, American journal of surgery.
[2] C. Carnaghi,et al. Adjuvant chemotherapy in resected bile duct cancer: A systematic review and meta-analysis of randomized trials. , 2019, Critical reviews in oncology/hematology.
[3] C. la Vecchia,et al. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. , 2019, Journal of hepatology.
[4] Yajin Chen,et al. Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis. , 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[5] Y. Shioyama,et al. Carbon-ion radiotherapy for cholangiocarcinoma: a multi-institutional study by and the Japan carbon-ion radiation oncology study group (J-CROS) , 2019, Oncotarget.
[6] J. Sicklick,et al. NCCN Guidelines Insights: Hepatobiliary Cancers, Version 2.2019: Featured Updates to the NCCN Guidelines , 2019 .
[7] J. Sicklick,et al. Guidelines Insights: Hepatobiliary Cancers, Version 2.2019. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.
[8] F. Shen,et al. [Progress on surgical treatment of intrahepatic cholangiocarcinoma]. , 2019, Zhonghua wai ke za zhi [Chinese journal of surgery].
[9] Chen-hai Liu,et al. The effect of adjuvant chemotherapy in resectable cholangiocarcinoma: A meta-analysis and systematic review. , 2019, Hepatobiliary & pancreatic diseases international : HBPD INT.
[10] S. Maithel,et al. Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] O. Riesterer,et al. Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[12] C. Lo,et al. Adjuvant chemotherapy improves oncological outcomes of resectable intrahepatic cholangiocarcinoma , 2019, Medicine.
[13] Ya Cao,et al. Systemic inflammation score predicts survival in patients with intrahepatic cholangiocarcinoma undergoing curative resection , 2019, Journal of Cancer.
[14] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[15] Bo Chen,et al. Benefit of adjuvant radiotherapy following narrow-margin hepatectomy in patients with intrahepatic cholangiocarcinoma that adhere to major vessels , 2018, Cancer management and research.
[16] Szu-Yuan Wu,et al. Outcomes of adjuvant treatments for resectable intrahepatic cholangiocarcinoma: Chemotherapy alone, sequential chemoradiotherapy, or concurrent chemoradiotherapy. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[17] S. Curley,et al. The role of surgery and adjuvant therapy in lymph node–positive cancers of the gallbladder and intrahepatic bile ducts , 2018, Cancer.
[18] Ya Cao,et al. Intrahepatic cholangiocarcinoma patients without indications of lymph node metastasis not benefit from lymph node dissection , 2017, Oncotarget.
[19] Y. Morine,et al. Effect of Adjuvant Gemcitabine Combined with Low-dose 5-Fluorouracil and Cisplatin Chemotherapy for Advanced Biliary Carcinoma. , 2017, Anticancer research.
[20] A. Ejaz,et al. Impact of adjuvant chemotherapy on survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis. , 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[21] Q. Xia,et al. Transarterial Chemoembolization: A Favorable Postoperative Management to Improve Prognosis of Hepatitis B Virus-associated Intrahepatic Cholangiocarcinoma after Surgical Resection , 2017, International journal of biological sciences.
[22] W. Lau,et al. Actual over 10-year survival after liver resection for patients with intrahepatic cholangiocarcinoma , 2017, Oncotarget.
[23] M. Manns,et al. The effect of adjuvant chemotherapy in patients with intrahepatic cholangiocarcinoma: a matched pair analysis , 2017, Journal of Cancer Research and Clinical Oncology.
[24] T. Pawlik,et al. Is Radiotherapy Warranted Following Intrahepatic Cholangiocarcinoma Resection? The Impact of Surgical Margins and Lymph Node Status on Survival , 2016, Annals of Surgical Oncology.
[25] Dong-hao Wu,et al. Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk Stratification. , 2015, The oncologist.
[26] T. Pawlik,et al. Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma , 2015, Annals of Surgical Oncology.
[27] Q. Ye,et al. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection , 2014, Liver international : official journal of the International Association for the Study of the Liver.
[28] Rui-qing Liu,et al. Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors , 2013, Cancer Cell International.
[29] T. Pawlik,et al. Intra-arterial Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis , 2013, Annals of Surgical Oncology.
[30] N. Yang,et al. Postoperative adjuvant transcatheter arterial chemoembolisation improves survival of intrahepatic cholangiocarcinoma patients with poor prognostic factors: results of a large monocentric series. , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[31] Jiamei Yang,et al. Adjuvant Transcatheter Arterial Chemoembolization for Intrahepatic Cholangiocarcinoma after Curative Surgery: Retrospective Control Study , 2011, World Journal of Surgery.
[32] I-S Lee,et al. Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma. , 2011, Clinical radiology.
[33] Zhao-You Tang,et al. Benefit of radiotherapy for 90 patients with resected intrahepatic cholangiocarcinoma and concurrent lymph node metastases , 2010, Journal of Cancer Research and Clinical Oncology.